Aswathy R. Devan
Impact in
-
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Glycosylation and Glycoproteins Research 2
- Oncology 7
- Cancer Immunotherapy and Biomarkers 2
- Drug Transport and Resistance Mechanisms 2
- Co-authors
- Lekshmi R. Nath (18 shared papers)Bhagyalakshmi Nair (14 shared papers)Vinod Balachandran (2 shared papers)K Pavithran (2 shared papers)Javad Sharifi‐Rad (1 shared paper)Daniela Călina (1 shared paper)Nikhil Ponnoor Anto (1 shared paper)Bijo Mathew (2 shared papers)
- Journals
- Clinical & Translational Oncology (1 paper)Biotechnology and Applied Biochemistry (1 paper)Naunyn-Schmiedeberg s Archives of Pharmacology (1 paper)International Journal of Pharmaceutics (1 paper)Drug Discovery Today (1 paper)
- Partner nations
- IndiaUnited StatesSouth Korea
In The Last Decade
Aswathy R. Devan
17 papers receiving 294 citations
Peers
Comparison fields: 5 of 80
- Hepatology 34
- Oncology 83
- Immunology 59
- Molecular Medicine 11
- Pharmacology 19
Countries citing papers authored by Aswathy R. Devan
This map shows the geographic impact of Aswathy R. Devan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aswathy R. Devan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aswathy R. Devan more than expected).
Fields of papers citing papers by Aswathy R. Devan
This network shows the impact of papers produced by Aswathy R. Devan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aswathy R. Devan. The network helps show where Aswathy R. Devan may publish in the future.
Co-authors
The 13 scholars most cited alongside Aswathy R. Devan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 83 | |
| 2 | 2021 | 41 | |
| 3 | 2022 | 22 | |
| 4 | 2024 | 20 | |
| 5 | 2021 | 20 | |
| 6 | 2021 | 17 | |
| 7 | 2021 | 16 | |
| 8 | 2021 | 15 | |
| 9 | 2020 | 14 | |
| 10 | 2021 | 13 | |
| 11 | 2022 | 9 | |
| 12 | 2023 | 9 | |
| 13 | 2021 | 6 | |
| 14 | 2024 | 6 | |
| 15 | 2023 | 5 | |
| 16 | 2022 | 4 | |
| 17 | 2025 | 3 | |
| 18 | 2025 | 0 |
About Aswathy R. Devan
Aswathy R. Devan is a scholar working on Molecular Biology, Oncology, Immunology, Epidemiology and Hepatology, having authored 18 papers that have together received 303 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Glycosylation and Glycoproteins Research (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer Mechanisms and Therapy (2 papers), Immunotherapy and Immune Responses (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Hepatology (34 citations), Oncology (83 citations), Immunology (59 citations), Molecular Medicine (11 citations) and Pharmacology (19 citations). Aswathy R. Devan has collaborated with scholars based in India, United States and South Korea. Frequent co-authors include Lekshmi R. Nath, Bhagyalakshmi Nair, Vinod Balachandran, K Pavithran, Javad Sharifi‐Rad, Daniela Călina, Nikhil Ponnoor Anto, Bijo Mathew, Hoon Kim and Kanjoormana Aryan Manu. Their work appears in journals such as Clinical & Translational Oncology, Biotechnology and Applied Biochemistry, Naunyn-Schmiedeberg s Archives of Pharmacology, International Journal of Pharmaceutics and Drug Discovery Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.